EU says AstraZeneca Covid-19 vaccine production capacity in Belgium has sharply increased
The factory, now owned by US firm Thermo Fisher, had been seen as the main cause of a large cut in supplies by the Anglo-Swedish firm to the EU in the first quarter of this year
European Union industry commissioner Thierry Breton said on Wednesday the Covid-19 vaccine production capacity of a factory in Belgium that produced shots for AstraZeneca had "drastically" increased.
The factory, now owned by US firm Thermo Fisher, had been seen as the main cause of a large cut in supplies by the Anglo-Swedish firm to the EU in the first quarter of this year.